Last reviewed · How we verify
Mycobacteriophage Muddy_HRMN0052 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Mycobacteriophage Muddy_HRMN0052 (Mycobacteriophage Muddy_HRMN0052) — Vancouver Coastal Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mycobacteriophage Muddy_HRMN0052 TARGET | Mycobacteriophage Muddy_HRMN0052 | Vancouver Coastal Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mycobacteriophage Muddy_HRMN0052 CI watch — RSS
- Mycobacteriophage Muddy_HRMN0052 CI watch — Atom
- Mycobacteriophage Muddy_HRMN0052 CI watch — JSON
- Mycobacteriophage Muddy_HRMN0052 alone — RSS
Cite this brief
Drug Landscape (2026). Mycobacteriophage Muddy_HRMN0052 — Competitive Intelligence Brief. https://druglandscape.com/ci/mycobacteriophage-muddy-hrmn0052. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab